1. Short title This Act may be cited as the Preventing Essential Medical Device Shortages Act of 2020 . 2. Discontinuance or interruption in the production of essential medical devices Chapter V of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 351 et seq.) is amended by inserting after section 506I the following: 506J. Discontinuance or interruption in the production of essential medical devices (a) In general The manufacturer of an essential device shall notify the Secretary, in accordance with subsection (b), of a permanent discontinuance in the manufacture of the essential device or an interruption of the manufacture of the essential device that is likely to lead to a meaningful disruption in the supply of that device in the United States, and the reasons for such discontinuance or interruption. (b) Timing A notice required under subsection (a) shall be submitted to the Secretary— (1) at least 6 months prior to the date of the discontinuance or interruption